65,437 trials
Non-Small Cell Lung Cancer
Primary: Objective Response Rate (ORR) by Week 19 — 45.3; 44.6 percentage of participants
Rheumatoid Arthritis
Primary: Number of Subjects Achieving American College of Rheumatology 20% (ACR20) Response at Week 12 — 19; 30; 33; 40 Participants — p== 0.033
Plaque Psoriasis
Primary: Percentage of Participants Achieving a Psoriasis Area Sensitivity Index 75% (PASI-75) Response at Week 12 (Part 1) — 65.6; 61.2; 5.8; 48.2 Percentage of participants…
Exudative Macular Degeneration
Primary: Change From Baseline Visual Acuity at 6 Months — 3.8 number of letters
Viral Upper Respiratory Tract Infection
Primary: Total Symptom Scores — 22.5; 34.2; 36.2; 33.5 units on a scale
Bronchopulmonary Dysplasia
Primary: Incidence of Bronchopulmonary Dysplasia (BPD) — 76; 84 percentage w/ BPD — p=0.20
Mental Illness · Tobacco Smoking · Psychotic Disorders
Primary: Number of Participants Who Utilized Smoking Cessation Treatment — 2; 1 Participants — p=0.65
Unilateral Retinoblastoma
Primary: Number of Patients Experiencing Feasibility Failure — 4 participants
Neisseria Meningitidis · Haemophilus Influenzae Type b
Primary: Percentage of Subjects With Anti-Polyribosylribitol Phosphate (Anti-PRP) Antibody Concentrations Greater Than or Equal to (≥) 1.0 µg/mL — 98.2; 97.2 Percentage of subjects
Kidney Transplant
Primary: Number of Subjects With Antibody-Mediated Rejection (AMR) in the First 3 Months After Living Donor Kidney Transplantation — 2 Participants
Pneumonia, Bacterial
Primary: Number of Participants Surviving Through LFU Visit — 191; 196; 64; 57 Participants — p=0.4263
Clear Cell Renal Cell Carcinoma · Recurrent Renal Cell Carcinoma · Stage IV Renal Cell Cancer
Primary: Progression-free Survival at 24 Weeks — 52; 27 percentage of participants
HIV Infection · Bone Loss · Osteopenia
Primary: Baseline-Adjusted Means for C-terminal Telopeptide of Collagen (CTx) Levels — 0.092; 0.297; 0.122; 0.331 ng/ml
Non-Small Cell Lung Cancer Stage IV
Primary: Progression Free Survival (PFS) — 2.53; 4.21 months — p=0.0068
Low Back Pain
Primary: Functional Impairment as Measured on the Roland Morris Disability Questionnaire — 10.9; 9.4; 8.1 units on a scale